<DOC>
	<DOCNO>NCT01438788</DOCNO>
	<brief_summary>- This 2 stage exploratory study 3-month observational phase natural course , follow 12-month , open-label , non-comparative , single-arm , phase II pilot study efficacy , safety tolerability low-protein diet ( LPD ) 8 adult patient Bethlem myopathy ( BM ) Ullrich congenital muscular dystrophy ( UCMD ) . - Objective trial test effect normocaloric LPD reactivate autophagy BM/UCMD patient . The primary end point study change muscle biopsy Beclin 1 , marker autophagy , 1 year LPD treatment compare baseline . - The rationale rest discovery ( ) mitochondrial dysfunction mediate inappropriate opening PTP play key role collagen VI myopathy ; ( ii ) defective autophagy impair removal defective mitochondrion amplifies defect ; ( iii ) reactivation autophagy low-protein diet treatment cyclosporine A , mitochondrial PTP inhibitor , cure Co6a1-/- mouse , hint common target among beneficial treatment - namely autophagy . - Specific aim project ( ) study modification clinical , nutritional laboratory parameter cohort patient BM/UCMD 3-month observational period start LPD treatment ; ( ii ) ass effect normocaloric LPD correct defective autophagy muscle patient ; ( iii ) test new non-invasive biomarkers activation autophagy examine blood mirror effect LPD muscle biopsy ; ( iv ) ass clinical efficacy safety LPD innovative combination complementary measure nutritional status patient . - The anticipated output define validate therapeutic nutritional approach autophagy upregulation BM/UCMD .</brief_summary>
	<brief_title>Low Protein Diet Patients With Collagen VI Related Myopathies</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Sclerosis</mesh_term>
	<criteria>Males female age â‰¥18 year . Women childbearing age must negative pregnancy test must use adequate contraception study . Clinical molecular diagnosis Bethlem myopathy Ullrich congenital muscular dystrophy . No previous treatment CsA within 6 month prior start study . Willing able adhere study visit schedule protocol requirement . Written inform consent sign . Current history liver renal disease . Pregnant breastfeed woman . Any serious internal medicine condition interfere study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Bethlem myopathy</keyword>
	<keyword>Ullrich congenital muscular dystrophy</keyword>
	<keyword>Low protein diet</keyword>
	<keyword>Autophagy</keyword>
	<keyword>Pilot clinical trial</keyword>
</DOC>